Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 113-92-8
2. Chloropheniramine Maleate
3. R-chlorpheniramine Maleate
4. Chlorphenamine Maleate,(s)
5. Hms3369f09
6. Hms3371m22
7. Hms3373a05
8. Hms3393l14
9. Hms3394e15
10. Hms3655g14
11. Bcp09631
12. Akos030228309
13. Sb19136
14. Db-041191
15. Ft-0623712
16. Ft-0665003
17. Ft-0665004
18. Ft-0665005
19. Z2210694610
| Molecular Weight | 390.9 g/mol |
|---|---|
| Molecular Formula | C20H23ClN2O4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | 390.1346349 g/mol |
| Monoisotopic Mass | 390.1346349 g/mol |
| Topological Polar Surface Area | 90.7 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 368 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 1 |
| Covalently Bonded Unit Count | 2 |
| 1 of 6 | |
|---|---|
| Drug Name | HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE |
| Active Ingredient | CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE |
| Company | ACELLA PHARMS LLC (Application Number: A206891) |
| 2 of 6 | |
|---|---|
| Drug Name | HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE |
| Active Ingredient | CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Company | PADDOCK LLC (Application Number: A204627) |
| 3 of 6 | |
|---|---|
| Drug Name | VITUZ |
| Active Ingredient | CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE |
| Company | CYPRESS PHARM (Application Number: N204307) |
| 4 of 6 | |
|---|---|
| Drug Name | HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE |
| Active Ingredient | CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Company | BIO-PHARM INC (Application Number: A206660) |
| 5 of 6 | |
|---|---|
| Drug Name | HYDROCODONE BITARTRATE,CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE |
| Active Ingredient | CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Company | MAYNE PHARMA INC (Application Number: A205657) |
| 6 of 6 | |
|---|---|
| Drug Name | ZUTRIPRO |
| Active Ingredient | CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Company | CYPRESS PHARM (Application Number: N022439) |
ABOUT THIS PAGE
A AC1L1QK4 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AC1L1QK4, including repackagers and relabelers. The FDA regulates AC1L1QK4 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AC1L1QK4 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AC1L1QK4 supplier is an individual or a company that provides AC1L1QK4 active pharmaceutical ingredient (API) or AC1L1QK4 finished formulations upon request. The AC1L1QK4 suppliers may include AC1L1QK4 API manufacturers, exporters, distributors and traders.
click here to find a list of AC1L1QK4 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A AC1L1QK4 written confirmation (AC1L1QK4 WC) is an official document issued by a regulatory agency to a AC1L1QK4 manufacturer, verifying that the manufacturing facility of a AC1L1QK4 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting AC1L1QK4 APIs or AC1L1QK4 finished pharmaceutical products to another nation, regulatory agencies frequently require a AC1L1QK4 WC (written confirmation) as part of the regulatory process.
click here to find a list of AC1L1QK4 suppliers with Written Confirmation (WC) on PharmaCompass.
AC1L1QK4 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AC1L1QK4 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AC1L1QK4 GMP manufacturer or AC1L1QK4 GMP API supplier for your needs.
A AC1L1QK4 CoA (Certificate of Analysis) is a formal document that attests to AC1L1QK4's compliance with AC1L1QK4 specifications and serves as a tool for batch-level quality control.
AC1L1QK4 CoA mostly includes findings from lab analyses of a specific batch. For each AC1L1QK4 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AC1L1QK4 may be tested according to a variety of international standards, such as European Pharmacopoeia (AC1L1QK4 EP), AC1L1QK4 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AC1L1QK4 USP).
LOOKING FOR A SUPPLIER?
